Workflow
Securities Fraud
icon
Search documents
Johnson Fistel, PLLP Investigates Manhattan Associates, Inc. for Potential Violations of Federal and State Law – Shareholders are Encouraged to Reach Out for More Information
GlobeNewswire News Room· 2025-04-30 22:20
SAN DIEGO, April 30, 2025 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP notifies investors that it has commenced an investigation into whether Manhattan Associates, Inc. (NASDAQ: MANH) complied with the federal securities laws and state law regarding fiduciary duties owed to the Company and its shareholders. Did you purchase Manhattan Associates securities? If you purchased securities and suffered losses on your investment, or if you are a long time continuous holder of Manhattan Associates stock, join our inves ...
NSSC Investors Have Opportunity to Lead NAPCO Security Technologies, Inc. Securities Fraud Lawsuit
Prnewswire· 2025-04-30 06:11
NEW YORK, April 30, 2025 /PRNewswire/ --Why: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of NAPCO Security Technologies, Inc. (NASDAQ: NSSC) between February 5, 2024 and February 3, 2025, both dates inclusive (the "Class Period"). If you wish to serve as lead plaintiff, you must move the Court no later than June 24, 2025.So what: If you purchased NAPCO securities during the Class Period you may be entitled to compens ...
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Amerant Bancorp Inc. - AMTB
GlobeNewswire News Room· 2025-04-29 20:55
Core Viewpoint - Pomerantz LLP is investigating potential securities fraud or unlawful business practices involving Amerant Bancorp Inc. and its officers or directors, following disappointing financial results for Q1 2025 that led to a significant drop in stock price [1][3]. Financial Performance - Amerant Bancorp reported GAAP earnings per share of $0.28 for Q1 2025, which was $0.12 below consensus estimates [3]. - The company's loans remained relatively flat quarter over quarter due to increased payoffs and paydowns offsetting new production [3]. - Following the earnings announcement, Amerant's stock price decreased by $2.55, or 13.09%, closing at $16.93 per share on April 24, 2025 [3].
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Landstar System, Inc. - LSTR
GlobeNewswire News Room· 2025-04-29 20:50
Core Viewpoint - Landstar System, Inc. is under investigation for potential securities fraud and unlawful business practices following the disclosure of significant supply chain fraud that may impact its earnings [1][3]. Group 1: Company Disclosures - On April 2, 2025, Landstar identified a significant supply chain fraud that could adversely affect its first quarter 2025 earnings per share by $0.35 to $0.50, leading to the withdrawal of its previous earnings guidance [3]. - Following this announcement, Landstar's stock price dropped by $13.30, or 8.75%, closing at $138.63 on April 3, 2025 [3]. - On April 25, 2025, Landstar announced it would be unable to file its quarterly report on time due to ongoing evaluations of accounting and internal control matters related to the identified fraud [4]. - This news resulted in a further decline in Landstar's stock price by $4.92, or 3.52%, closing at $135.00 on April 25, 2025 [4]. Group 2: Legal Investigation - Pomerantz LLP is investigating claims on behalf of Landstar investors regarding potential securities fraud and unlawful business practices by the company and its officers or directors [1].
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of FTI Consulting, Inc. - FCN
GlobeNewswire News Room· 2025-04-29 20:47
Core Viewpoint - Pomerantz LLP is investigating potential securities fraud or unlawful business practices involving FTI Consulting, Inc. and its officers or directors [1] Financial Performance - FTI Consulting reported first-quarter 2025 revenue of $898.3 million, a year-over-year decline of 3.3%, missing consensus estimates by $8.38 million [3] - The company reported net income of $61.8 million, down from $80 million in the same period last year, attributed to lower revenues and a $25.3 million special charge related to severance and employee-related costs [3] - Following the financial results announcement, FTI's stock price decreased by $6.60 per share, or 3.92%, closing at $161.91 per share on April 24, 2025 [3]
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RH - RH
GlobeNewswire News Room· 2025-04-29 17:29
Core Viewpoint - Pomerantz LLP is investigating claims of potential securities fraud or unlawful business practices involving RH and its officers or directors [1] Group 1: Financial Performance and Allegations - Hunterbrook Media published a report on January 24, 2025, alleging that RH may be "running out of money" and highlighted a cumulative shortfall of $1.4 billion in free cash flow over the last 20 quarters [3] - The report also stated that RH's claims of rapid growth appear to be unsubstantiated, leading to a stock price decline of $15.72 per share, or 3.6%, closing at $418.74 on the same day [3] Group 2: Legal Context - Pomerantz LLP is recognized as a leading firm in corporate, securities, and antitrust class litigation, with a history of fighting for victims of securities fraud and corporate misconduct [4] - The firm has a legacy of recovering multimillion-dollar damages for class members, continuing the tradition established by its founder, Abraham L. Pomerantz [4]
Ready Capital Corporation Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before May 5, 2025 to Discuss Your Rights – RC
GlobeNewswire News Room· 2025-04-29 17:13
NEW YORK, April 29, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Ready Capital Corporation ("Ready Capital" or the "Company") (NYSE: RC) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Ready Capital investors who were adversely affected by alleged securities fraud between August 8, 2024 and March 2, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/ready-capita ...
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of iRobot Corporation – IRBT
GlobeNewswire News Room· 2025-04-29 16:45
NEW YORK, April 29, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of iRobot Corporation (“iRobot” or the “Company”) (NASDAQ: IRBT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether iRobot and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.  [Click here for information about joining the class action] On March 12, 20 ...
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of XP Inc. – XP
GlobeNewswire News Room· 2025-04-29 16:43
Core Viewpoint - Pomerantz LLP is investigating claims of potential securities fraud and unlawful business practices involving XP Inc. and its officers or directors [1] Group 1: Investigation and Allegations - Pomerantz LLP is representing investors of XP Inc. in an investigation regarding possible securities fraud [1] - Grizzly Research published a report alleging that XP is operating a Ponzi scheme through derivatives sales misrepresented as proprietary trading profits [3] - Following the report's release, XP's stock price dropped by $0.82, or 5.48%, closing at $14.14 per share on March 12, 2025 [3] Group 2: Company Background - Pomerantz LLP is recognized as a leading firm in corporate, securities, and antitrust class litigation, with a history of over 85 years in fighting for victims of securities fraud [4] - The firm has successfully recovered numerous multimillion-dollar damages awards for class members [4]
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Sarepta Therapeutics, Inc. – SRPT
GlobeNewswire News Room· 2025-04-29 16:09
NEW YORK, April 29, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Sarepta Therapeutics, Inc. (“Sarepta” or the “Company”) (NASDAQ: SRPT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Sarepta and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.  [Click here for information about joining the class action] On Ma ...